Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment.
about
Signatures of breast cancer metastasis at a glanceMarkers for the identification of late breast cancer recurrence.Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin.Improved method increases sensitivity for circulating hepatocellular carcinoma cells.An optimised direct lysis method for gene expression studies on low cell numbers.Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer.Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.Analysis of circulating tumor cells in colorectal cancer liver metastasis patients before and after cryosurgeryBreast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.Plasticity of disseminating cancer cells in patients with epithelial malignancies.Enrichment, detection and clinical significance of circulating tumor cells.Circulating tumor cells: utopia or reality?Concomitant resistance and early-breast cancer: should we change treatment strategies?The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.Circulating tumor cells as promising novel biomarkers in solid cancers.Gene expression profiling and DNA methylation analyses of CTCs.Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.Personalized therapy for breast cancer: a dream or a reality?Dietary selenium supplementation modifies breast tumor growth and metastasis.Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients.Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer.Aptamer-functionalized nano/micro-materials for clinical diagnosis: isolation, release and bioanalysis of circulating tumor cells.
P2860
Q28071451-34EF59CE-2149-49B6-9FA3-A9A1D5E5A309Q35018949-F2AD3D32-7E89-42A1-92A0-CF37758872A5Q35157131-E5525868-538B-4C73-A997-61E7E323A6EAQ35169325-AD797932-BCFC-415C-85E6-9373C1D42BC8Q35917630-E164323F-DFC5-47ED-B536-89738048B367Q36525788-44759D30-8CA3-4C1C-9DF6-83EAAD1A5321Q36771900-D040AE76-C906-4800-A47B-F7C7B3230C82Q36902974-57EC131A-B153-4B40-B04E-C67217343489Q36959162-3230E0B6-73F6-4E4A-99B6-871FBD4B18BFQ37282976-C317FDE5-6D08-46A8-82B3-BF0F4827DCC2Q37405531-671B9CCB-A4D0-4E8B-8E56-5FBE8222EE99Q38021683-7E027ECD-60C8-4BE0-B384-FDCC28385D71Q38102590-3F9B9200-6D6B-4B4A-8BBF-16480D99D834Q38131799-22CA3562-113E-4486-87D2-77C81489A985Q38171964-F11C5B5B-DD6A-4B3C-8B77-F5DE0AB17BD2Q38175044-E8491188-FA2D-47E4-BEFB-DB66CA8ECEE4Q38196920-B536F80F-81CC-40BC-A7B0-FC72F77F71BBQ38734877-3C4247DB-63C0-4571-85FA-964A51D7738DQ38949124-C9BA4171-3897-4A9F-993B-709C6A3379C4Q39374969-5C9F5B2D-9B7F-4F1A-BC1F-F810DD3E8399Q46418605-05988C20-36CF-4EC8-9A02-EE111320907AQ47141377-DF0B4BE2-BDBF-4094-9353-A0B7D3F098ADQ48295235-14D27A50-588F-43AF-8B3D-5C8194F3A22CQ51022761-A4364FCD-4686-4A94-BCDA-DB88A82187FF
P2860
Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular characterization of ...... dividualized cancer treatment.
@en
type
label
Molecular characterization of ...... dividualized cancer treatment.
@en
prefLabel
Molecular characterization of ...... dividualized cancer treatment.
@en
P2093
P2860
P1476
Molecular characterization of ...... dividualized cancer treatment.
@en
P2093
Areti Strati
Athina Markou
Evi S Lianidou
P2860
P2888
P304
P356
10.1007/S10555-012-9366-8
P577
2012-12-01T00:00:00Z
P5875
P6179
1012745524